DCT Strategies to Enhance Diversity in Clinical Trials 2023: Inclusion of Underrepresented Groups Crucial for Successful Trials
April 18, 2023 06:23 ET
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "DCT Strategies to Enhance Diversity in Clinical Trials - 2023" report has been added to ResearchAndMarkets.com's offering. In this report the...
Glioblastoma Multiforme Market Analysis Report 2023: Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecasts, 2021-2031
April 14, 2023 08:28 ET
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial...
LAG-3 Inhibitor Market, 2028
March 07, 2023 05:28 ET
|
Research and Markets
Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. In...
Chronic Lymphocytic Leukemia (CLL) Global Market Report 2023: Sector to Reach $20.8 Billion Across 15 Major Markets by 2031
February 17, 2023 07:53 ET
|
Research and Markets
Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment,...
Insights on the Parenteral Nutrition Global Market to 2027 - Key Players Include Baxter, B. Braun Melsungen, Fresenius Kabi, JW Pharmaceuticals and Sichuan Kelun Pharmaceuticals
February 13, 2023 06:43 ET
|
Research and Markets
Dublin, Feb. 13, 2023 (GLOBE NEWSWIRE) -- The "Parenteral Nutrition Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.The global...
4 Day Drafting Effective Pharmaceutical Patents Training Course: Explore the Latest Strategies and Gain Useful Insights and Practical Solutions to Your Drafting Issues (May 16-19, 2023)
February 06, 2023 04:08 ET
|
Research and Markets
Dublin, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The "Drafting Effective Pharmaceutical Patents Training Course" conference has been added to ResearchAndMarkets.com's offering. The highly complex area of...
The Views of 103 Italian Patient Groups on the Corporate Reputation of Pharma, 2021-2022: Roche Ranked 1st Overall with Novo Nordisk in 2nd and Pfizer in 3rd
January 12, 2023 08:53 ET
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups" report has been added to...
Patient Perspective of 151 German Patient Groups on the Corporate Reputation of Pharma, 2021-2022: Ranking of 24 Companies
January 12, 2023 06:38 ET
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups" report has been added...
Views of 258 Neurology Patient Groups on the Corporate Reputation of Pharma in 2022: Roche Ranked 1st, Novartis Ranked 2nd and Biogen Ranked 3rd
January 12, 2023 06:28 ET
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups" report has been...
The Views of 300 Asian Patient Groups on the he Corporate Reputation of Pharma, 2021-2022: Overall Gilead Sciences Ranked 1st, Pfizer Ranked 2nd, and ViiV Healthcare Ranked 3rd
January 12, 2023 06:23 ET
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups" report has been added to ...